ABOUT
TECHNOLOGY
Overview
Mechanism of Action
Pipeline
ADPKD
PATIENTS
INVESTORS
Overview
Press Releases
Events and Presentations
Financials & Filings
SEC Filings
Quarterly Results
Corporate Governance
Governance Documents
Board of Directors
Committee Composition
Analyst Coverage
Stock Information
Historical Stock Price
Investment Calculator
Insider Transactions
Fundamentals
Form 8937
Investor FAQs
Contact Us
CAREER
Toggle nav
Press Releases
.
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Investor Alerts
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
February 19, 2015
Regulus to Present at 2015 RBC Capital Markets' Healthcare Conference
Photos
1
February 18, 2015
Regulus Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights
- Achieved Key 2014 'Clinical Map Initiative' Goals to Advance microRNA Therapeutics Pipeline -
Photos
1
February 12, 2015
Regulus Announces Timing for Fourth Quarter and Year-End 2014 Financial Results Webcast and Conference Call
Photos
1
February 09, 2015
All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57
-Extended Follow-Up Shows 4/14 Patients Treated with a Single SC Dose of 2 mg/kg of RG-101 are Target Not Detected at Day 85 -
Photos
1
February 02, 2015
Regulus to Present at Two Upcoming Investor Conferences
Photos
1
Show
5
10
25
50
100
per page
«
1
…
42
43
44
45
46
47
48
…
64
»